Literature DB >> 19443361

Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancer.

Kazuhisa Tokuno1, Shoichi Hazama, Shigefumi Yoshino, Shin Yoshida, Masaaki Oka.   

Abstract

BACKGROUND: Although recent studies have shown that FoxP3 represent the most specific Treg marker only a few studies have reported on the presence of FoxP3(+)Treg in peripheral blood. PATIENTS AND METHODS: Peripheral blood mononuclear cells (PBMC) were harvested from 37 healthy volunteers and 94 patients with gastrointestinal cancer. The prevalence of Treg co-expressing CD4(+)FoxP3(+) was analyzed using flow cytometry.
RESULTS: The prevalence of Treg in the peripheral blood of gastrointestinal cancer patients was significantly higher than that in healthy volunteers (p=0.012). In early stage I cancer, Treg levels tended to be higher than those in healthy volunteers (p=0.069); these levels were significantly reduced after tumor resection (p=0.0027).
CONCLUSION: The prevalence of Treg was increased in patients with gastrointestinal cancer, even in the early stages of the disease. Since Treg levels decreased after curative resection, it is possible that tumor cells may have induced and expanded the Treg pool.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443361

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  A novel method for screening colorectal cancer by infrared spectroscopy of peripheral blood mononuclear cells and plasma.

Authors:  Eyal Barlev; Udi Zelig; Omri Bar; Cheli Segev; Shaul Mordechai; Joseph Kapelushnik; Ilana Nathan; Felix Flomen; Hanoch Kashtan; Ram Dickman; Osnat Madhala-Givon; Nir Wasserberg
Journal:  J Gastroenterol       Date:  2015-06-26       Impact factor: 7.527

Review 2.  The functional and prognostic implications of regulatory T cells in colorectal carcinoma.

Authors:  Xinhai Zhang; Sonia Kelaria; Justin Kerstetter; Jun Wang
Journal:  J Gastrointest Oncol       Date:  2015-06

3.  Differential expression of Helios, Neuropilin-1 and FoxP3 in head and neck squamous cell carcinoma (HNSCC) patients.

Authors:  A A Mohamed Adil; Anil Kumar Bommanabonia; Anandraj Vaithy; Sateesh Kumar; Mohammad Waseem; Shazia Jamal; Neesar Ahmed
Journal:  3 Biotech       Date:  2019-04-16       Impact factor: 2.406

4.  Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.

Authors:  Xiang-Liang Yuan; Lei Chen; Tong-Tong Zhang; Yan-Hui Ma; Yun-Lan Zhou; Yan Zhao; Wei-Wei Wang; Ping Dong; Liang Yu; Yan-Yun Zhang; Li-Song Shen
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

5.  The role of regulatory T cells in cancer.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

6.  Clinical evaluation of systemic and local immune responses in cancer: time for integration.

Authors:  Dmitriy W Gutkin; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2013-10-08       Impact factor: 6.968

7.  Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma.

Authors:  Myoung Jae Kang; Kyoung Min Kim; Jun Sang Bae; Ho Sung Park; Ho Lee; Myoung Ja Chung; Woo Sung Moon; Dong Geun Lee; Kyu Yun Jang
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

8.  CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer.

Authors:  Michelle Hong; Jian Hang Lam; Si-Lin Koo; Clarinda Wei Ling Chua; Kah Ling Lim; Felicia Wee; Wei Keat Wan; Wei Qiang Leow; Joo Guan Yeo; Iain Bee Huat Tan; Joe Yeong; Tony Kiat Hon Lim; Tong Seng Lim
Journal:  Cancer Immunol Immunother       Date:  2021-02-02       Impact factor: 6.630

9.  Early detection of breast cancer using total biochemical analysis of peripheral blood components: a preliminary study.

Authors:  Udi Zelig; Eyal Barlev; Omri Bar; Itai Gross; Felix Flomen; Shaul Mordechai; Joseph Kapelushnik; Ilana Nathan; Hanoch Kashtan; Nir Wasserberg; Osnat Madhala-Givon
Journal:  BMC Cancer       Date:  2015-05-15       Impact factor: 4.430

10.  Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients.

Authors:  Marieke A van Leeuwen; M Fleur du Pré; Roy L van Wanrooij; Lilian F de Ruiter; H Rolien C Raatgeep; Dicky J Lindenbergh-Kortleve; Chris J Mulder; Lissy de Ridder; Johanna C Escher; Janneke N Samsom
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.